---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-090202"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2025-06-26T23:59:59+00:00"
generated_at: "2026-05-18T17:23:50.906484+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics raises ~$2.05M in registered direct offering of stock and pre-funded warrants

## Summary
- 338,725 shares at $3.36; 271,674 pre-funded warrants at $3.359/share.
- Total gross proceeds ~$2.05M; offering closed June 24, 2025.
- Net proceeds for general corporate purposes, including working capital and capex.
- Offered under effective shelf registration statement (File No. 333-266841).
- Pre-funded warrants have $0.001 exercise price; 4.99% or 9.99% beneficial ownership limit.

## SEC filing metadata
- accession: 0000950170-25-090202
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2025-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017025090202/0000950170-25-090202-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017025090202/tcrt-20250620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-090202
- JSON: https://secwatch.observer/filing/0000950170-25-090202.json
- Plain text: https://secwatch.observer/filing/0000950170-25-090202.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.